Sentence examples for the circulating tumor from inspiring English sources

Little attention has been placed on the interactions of the circulating tumor cells and the microenvironment of the circulation (i.e., the third microenvironment).

Another source of antigenically responsible autologous tumor cells can be the circulating tumor cells (CTC), a distinct population of cancer cells found in circulation in blood.

Liquid biopsy to access the circulating tumor DNA is a promising surrogate for invasive tumor genotyping.

Relocation mechanisms of the circulating tumor cells (CTCs) from the primary site to the secondary site through the blood vessel network cause tumor metastasis.

Little attention has been placed on targeting the microenvironments of the primary tumor site, the circulating tumor cells, or the metastatic or secondary (target) tumor site and how cancer cells move among them.

Since the 1950s, many studies have demonstrated the presence of CTC in blood and some of them even shed light that there may be prognostic value on the circulating tumor cells in patients with breast cancer (Colombo et al. 1959; Wilson 1959; Rohmsdahl et al. 1960; Soost 1960; Graeber 1961; Rohmsdahl et al. 1961; Saito 1961; Wuest and Birk 1962; Candar et al. 1962).

Another explanation for these observations may be that with advanced disease, mature circulating B cells home into increasing tumor sites, thus reducing the circulating tumor-reactive B cell compartment in these patients.

Tumor cells from solid tumors are shed into the circulation and these circulating tumor cells (CTC) may serve as a liquid biopsy to guide therapy.

It has been known for a long time that cells detach from primary tumors and reach different organs through the body's circulating system, therefore giving them the name "circulating tumor cells" (CTC).

This is one of the reasons circulating tumor cells may prove superior to PSA as a biomarker in patients receiving cytotoxic therapy for castrate-resistant disease.

For lung metastasis and assays evaluating the number of circulating tumor cells in the blood non-parametric the Mann Whitney Wilcoxon rank sum test was used.